RESOLUTION THERAPEUTICS
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
RESOLUTION THERAPEUTICS
Industry:
Biopharma Biotechnology Life Science
Founded:
2017-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Total Employee:
11+
Status:
Active
Total Funding:
26.6 M GBP
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
AffyImmune Therapeutics
AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Helperby Therapeutics
Helperby Therapeutics (Helperby) is a biopharmaceutical company dedicated to developing the next generation of lifesaving antibiotics.
Kither Biotech
Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases
Reflection Therapeutics
Reflection Therapeutics is developing cell therapy technology against neuroinflammation across the board.
Current Advisors List
Current Employees Featured
Founder
Investors List
Syncona Partners LLP
Syncona Partners LLP investment in Series A - Resolution Therapeutics
More informations about "Resolution Therapeutics"
Resolution Therapeutics - Unlocking regenerative macrophage …
Resolution is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. Our work builds on more than a decade of cutting-edge research …See details»
About us - Resolution Therapeutics
At Resolution, we are developing a macrophage cell therapy product with first-in-class potential to treat patients at risk of hepatic decompensation, with the aim of preventing further …See details»
Science - Resolution Therapeutics
At Resolution Therapeutics, we are developing regenerative macrophage cell therapy to promote organ repair.See details»
Resolution Therapeutics - Crunchbase Company Profile & Funding
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases. An engineered autologous macrophage cell therapy designed to …See details»
Resolution Therapeutics’ founders present clinical proof-of
Nov 13, 2023 · Resolution has developed RTX001, a leading first-in-class engineered autologous macrophage cell therapy designed to transform patient outcomes by delivering increased anti …See details»
Resolution Therapeutics | VentureRadar
Resolution Therapeutics is developing macrophage cell therapies to treat diseases characterised by life-threatening inflammatory organ damage. The Company is built upon more than a …See details»
Resolution scores $83m to develop macrophage cell therapies
Oct 3, 2024 · Resolution Therapeutics has raised £63.5m ($83.3m) in a Series B financing round to develop its macrophage cell therapies. The UK-based company plans to use the money to …See details»
Resolution Therapeutics - LinkedIn
Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between...See details»
Resolution Therapeutics Announces £63.5 Million Series B …
Mar 10, 2024 · Resolution Therapeutics is a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the treatment of inflammatory …See details»
Resolution Therapeutics Strengthens its Executive …
London, 10 July 2023 – Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical company developing macrophage cell therapies to treat advanced liver disease, today announced the appointment of Simon Ramsden …See details»
Resolution Therapeutics’ founders present clinical proof-of …
Nov 13, 2023 · Resolution Therapeutics is a biotechnology company developing macrophage cell therapies to treat end-stage liver disease. The company is built upon more than a decade of …See details»
Resolution Therapeutics secures $83M to advance liver therapy
Oct 3, 2024 · Resolution’s lead candidate therapy is designed to regenerate the liver in end stage liver disease patients by increasing anti-fibrotic and anti-inflammatory effects.See details»
Resolution Therapeutics Announces New Clinical and Preclinical …
Nov 11, 2024 · Resolution Therapeutics Limited ("Resolution" or "Company"), a clinical-stage biopharmaceutical company spun out of the University of Edinburgh pioneering regenerative …See details»
Resolution Therapeutics Announces New Clinical and Preclinical …
Nov 11, 2024 · Resolution Therapeutics is a clinical-stage biopharmaceutical company pioneering regenerative macrophage therapy in inflammatory and fibrotic diseases. The Company …See details»
Resolution Therapeutics Receives MHRA Approval to Commence …
Jun 27, 2024 · Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company developing macrophage cell therapies to treat end-stage liver disease today …See details»
Resolution Therapeutics Announces New Breakthrough Clinical …
Resolution Therapeutics presents novel discovery platform for engineered macrophage cell therapy to enhance therapeutic efficacy.See details»
Resolution Therapeutics and CCRM sign collaboration agreement …
Nov 7, 2022 · Resolution Therapeutics is a biotechnology company developing macrophage cell therapies to treat advanced liver disease. The Company is built upon more than a decade of …See details»
Resolution Therapeutics Receives MHRA Approval to Commence …
Jun 27, 2024 · Resolution Therapeutics is a clinical-stage biopharmaceutical company pioneering macrophage cell therapy for transformative outcomes in inflammatory organ diseases.See details»
Resolution Therapeutics Announces New Breakthrough Clinical …
Jun 5, 2024 · Resolution Therapeutics is a clinical-stage biopharmaceutical company pioneering macrophage cell therapy for transformative outcomes in inflammatory organ diseases.See details»
Resolution Therapeutics’ engineered macrophage cell ... - BioWorld
Jun 27, 2024 · Resolution Therapeutics Ltd. has received approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a phase I/II study of its lead …See details»